| Genomic Medicine |
1 |
1 |
| Genetics |
0 |
0.78 |
| Cardiovascular Risk Management |
0 |
0.44 |
| Cardiometabolic Risk Factors |
0 |
0.43 |
| Peripheral Neuropathy |
0 |
0.99 |
| Atrial Fibrillation |
0 |
0.38 |
| Coronary Artery Disease (CAD) |
0 |
0.36 |
| Coronary Heart Disease Risk Factors |
0 |
0.35 |
| Neuropathy |
0 |
0.32 |
| Hypertension |
0 |
0.26 |
| Heart |
0 |
0.23 |
| Thromboembolism |
0 |
0.2 |
| Bone |
0 |
0.18 |
| Osteomyelitis |
0 |
0.16 |
| Vein |
0 |
0.14 |
| Body Mass Index |
0 |
0.09 |
| Europe |
0 |
0.09 |
| Meta-Analysis |
0 |
0.09 |
| Nerve |
0 |
0.09 |
| Electronic Medical Record |
0 |
0.08 |
| Chronic Venous Insufficiency |
0 |
0.07 |
| Deep Venous Thrombosis |
0 |
0.07 |
| Asthma |
0 |
0.05 |
| Birth |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Cardiovascular disease |
0 |
0.05 |
| Chronic Disease |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Colorado |
0 |
0.05 |
| Dermatoses |
0 |
0.05 |
| Diet |
0 |
0.05 |
| Electronic Health Record (EHR) |
0 |
0.05 |
| Erectile Dysfunction |
0 |
0.05 |
| Hand |
0 |
0.05 |
| Healthcare and Medical Technology |
0 |
0.05 |
| Hyperlipidemia |
0 |
0.05 |
| Lipids Management |
0 |
0.05 |
| Medical Records |
0 |
0.05 |
| Metabolism |
0 |
0.05 |
| Nutrition |
0 |
0.05 |
| Pedal |
0 |
0.05 |
| Quality of Life |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.05 |
| Socioeconomics |
0 |
0.05 |
| Thrombosis |
0 |
0.05 |
| Urinary Retention |
0 |
0.05 |
| Venous Insufficiency |
0 |
0.05 |